Risk of adverse outcomes in inflammatory bowel disease patients infected with SARS-CoV-2: a systematic review and meta-analysis.

Authors:
Chen L; Hu K; Cheng C; Hu Q; Zhang L and 4 more

Journal:
Int J Colorectal Dis

Publication Year: 2022

DOI:
10.1007/s00384-022-04265-w

PMCID:
PMC9589854

PMID:
36271206

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Int J Colorectal Dis

Abbreviation: Int J Colorectal Dis

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Gastroenterology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Downstaging after preoperative chemoradiation for locally advanced rectal cancer is associated with…
Kasheri E; Artinyan A; Oka K and 7 more (2024) - Transparency Score: 2/6
Ethnic disparities in pediatric appendicitis: the impact of hispanic ethnicity on presentation, com…
Chidiac C; Liu O; Gorijavolu R and 2 more (2024) - Transparency Score: 3/6
Findings in magnetic resonance imaging for restaging locally advanced rectal cancer.
Marjasuo S; Koskenvuo L; Lepistö A. (2024) - Transparency Score: 3/6
Long-term prognosis after stapled and hand-sewn ileal pouch-anal anastomoses for familial adenomato…
Tatsuta K; Sakata M; Iwaizumi M and 8 more (2024) - Transparency Score: 2/6
Long-term results and quality of life after stapled hemorrhoidopexy vs Doppler-guided HAL-RAR: a pr…
Lauricella S; Palmisano D; Brucchi F and 4 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Competing interestsThe authors declare no competing interests. Conflict of interestThe authors declare no competing interests. Competing interests The authors declare no competing interests. Conflict of interest The authors declare no competing interests."

Evidence found in paper:

"Funding This work was supported by the National Natural Science Foundation of China (82073618) and Epidemic Prevention and Control Research and Development projects in Henan Province (211100310900)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025